Dan Loughlin is a International Director Broker Lead of JLL's New Jersey office.
At JLL, Dan spearheads its Brokerage Services Division focusing on providing corporate representation in both the acquisition and disposition of commercial real estate, strategic planning and site development activities, with a focus in the pharmaceutical and biotech industry.
Dan sits on the JLL Americas Leadership Council and the Executive Committee of the Life Science Practice Group.
Dan has over 25 years of experience in the corporate real estate field with over $2.0 Billion in transactions involving over 8 million square feet.
Some of his corporate clients include Merck, Roche Molecular, ExxonMobil, Celgene, Linde, sanofi-aventis, Prudential, Roka Biosciences, Daiichi Sankyo, Savient Pharmaceutical and CIT.
Dan began his career at JLL in July of 2008 due to the merger of The Staubach Company. Prior to joining the firm, he was a Managing Principal of The Staubach Companys New Jersey Corporate Services division.
Dan joined Staubach in November 1998. In 1997, he was a Principal of Loughlin Stanton, LLC, a commercial real estate firm he founded with his partner, Thomas J. Stanton.
Prior to the formation of Loughlin Stanton, LLC, Dan was Senior Vice President for George Mintz & Company, Inc., a corporate real estate company where he specialized in Tenant Representation, Property Dispositions and Land Development and a Principal of Selkirk Construction Co.
Dan is a 2011 recipient of the JLL Champion of Excellence award.
Dan is a graduate of Long Island University CW Post Campus in Old Brookville, New York.
He earned a MCR (Master of Corporate Real Estate) accreditation, a professional designation focused on the strategic management of corporate real estate, and a SIOR accreditation (Society of Industrial and Office Realtors), a professional affiliate of the National Association of Realtors which is dedicated to the practice and maintenance of the highest professional and ethical standards.
Dan is a Board Member of the New Jersey Chapter of CoreNet Global, a Member of the New Jersey Biotechnology Council, Foundation Board Member of The Garden State Cancer Center Foundation in Belleville, New Jersey and a Capital Campaign Board Member for The Cancer Support Community of Central New Jersey.